Leucht K - Search Results

1

[Side effects of immune checkpoint inhibitor treatment of urological tumors].

Grimm MO, Gottschlich T, Ali N, Foller S, Leucht K. Grimm MO, et al. Among authors: leucht k. Urologe A. 2021 Jun;60(6):803-815. doi: 10.1007/s00120-021-01550-4. Epub 2021 Jun 8. Urologe A. 2021. PMID: 34100956 German.

2

[Risk-adapted therapy for metastatic renal cell carcinoma].

Grimm MO, Leucht K, Foller S, Grünwald V. Grimm MO, et al. Among authors: leucht k. Urologe A. 2020 Feb;59(2):155-161. doi: 10.1007/s00120-020-01131-x. Urologe A. 2020. PMID: 32006060 Review. German.

3

New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies.

Grimm MO, Leucht K, Grünwald V, Foller S. Grimm MO, et al. Among authors: leucht k. J Clin Med. 2020 Feb 19;9(2):565. doi: 10.3390/jcm9020565. J Clin Med. 2020. PMID: 32092974 Free PMC article. Review.

4

Re: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.

Grimm MO, Leucht K. Grimm MO, et al. Among authors: leucht k. Eur Urol. 2021 Mar;79(3):429-430. doi: 10.1016/j.eururo.2020.10.015. Epub 2020 Nov 2. Eur Urol. 2021. PMID: 33148473 No abstract available.

5

[Erratum to: Side effects of immune checkpoint inhibitor treatment of urological tumors].

Grimm MO, Gottschlich T, Ali N, Foller S, Leucht K. Grimm MO, et al. Among authors: leucht k. Urologe A. 2021 Jul 5. doi: 10.1007/s00120-021-01590-w. Online ahead of print. Urologe A. 2021. PMID: 34223943 German. No abstract available.

6

How to Deal with Renal Cell Carcinoma >7 cm: Radical Surgery.

Grimm MO, Leucht K. Grimm MO, et al. Among authors: leucht k. Eur Urol Open Sci. 2021 Sep 28;33:81-82. doi: 10.1016/j.euros.2021.09.001. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34632424 Free PMC article.

7

[Bacillus Calmette-Guérin (BCG) and alternatives : Drug treatment of high-risk non-muscle invasive bladder cancer].

Leucht K, Foller S, Grimm MO. Leucht K, et al. Urologe A. 2021 Nov;60(11):1400-1408. doi: 10.1007/s00120-021-01681-8. Epub 2021 Oct 28. Urologe A. 2021. PMID: 34709440 Review. German.

8

Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma.

Grimm MO, Leucht K, Foller S. Grimm MO, et al. Among authors: leucht k. J Clin Med. 2021 Nov 16;10(22):5339. doi: 10.3390/jcm10225339. J Clin Med. 2021. PMID: 34830621 Free PMC article. Review.

9

Influence of Prostate Artery Embolization on Different Qualities of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction.

Theurich AT, Leistritz L, Leucht K, Franiel T, Teichgräber U, Foller S, Grimm MO. Theurich AT, et al. Among authors: leucht k. Eur Urol Focus. 2022 Sep;8(5):1323-1330. doi: 10.1016/j.euf.2022.01.011. Epub 2022 Feb 4. Eur Urol Focus. 2022. PMID: 35125344

10

Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma.

Grimm MO, Schmitz-Dräger BJ, Zimmermann U, Grün CB, Baretton GB, Schmitz M, Foller S, Leucht K, Schostak M, Zengerling F, Schumacher U, Loidl W, Meran J. Grimm MO, et al. Among authors: leucht k. J Clin Oncol. 2022 Jul 1;40(19):2128-2137. doi: 10.1200/JCO.21.02631. Epub 2022 Mar 11. J Clin Oncol. 2022. PMID: 35275706 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters